Results 111 to 120 of about 42,297 (231)

Antinuclear Antibodies Predict Treatment Escalation and Biologic Switching in Rheumatoid Arthritis. [PDF]

Diagnostics (Basel)
Akar ZA, Yıldırım D, Çiftçi M, Işık Sula Z, Karaman S, Çevik R, Karakoç M, Em S, Batmaz İ, Oktayoğlu P, Çağlayan M.   +10 more
europepmc   +1 more source

Beyond Glucocorticoids: The Current Landscape and Prospects for Treating Immune Checkpoint Inhibitor‐Induced Autoimmunity

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
The rapid integration of immune checkpoint inhibitors (ICIs) into standard oncology protocols has birthed a new frontier in clinical rheumatology: immune‐related adverse events (irAEs). By disrupting the programmed cell death‐1 (PD‐1)/PD‐L1 and cytotoxic T‐lymphocyte‐associated protein 4 (CTLA‐4) axes to restore antitumor T cell activity, these ...
Xizi Hu, Ji Eun Ryoo, Brian S. Henick, Adam Mor   +3 more
wiley   +1 more source

Immunoprecipitation-mass spectrometry reveals known and novel (NatC, <i>BCS1L</i>) antinuclear antibodies in rheumatoid arthritis. [PDF]

RMD Open
De Leeuw J, Michiels B, Derua R, Vulsteke JB, Dillaerts D, Cockx M, Verschueren P, Bossuyt X.   +7 more
europepmc   +1 more source

antinuclear antibody

Citation: 'antinuclear antibody' in the IUPAC Compendium of Chemical Terminology, 5th ed.; International Union of Pure and Applied Chemistry; 2025. Online version 5.0.0, 2025. 10.1351/goldbook.12898 • License: The IUPAC Gold Book is licensed under Creative Commons Attribution-ShareAlike CC BY-SA 4.0 International for individual terms ...
openaire   +1 more source

Change in Antinuclear Antibodies After Lung Transplantation in Patients with Systemic Sclerosis. [PDF]

J Clin Med
Barreales-Rodríguez V, Guillen-Del-Castillo A, Berastegui C, López-Meseguer M, Monforte V, Saez-Gimenez B, Villar A, Ojanguren I, Codina-Clavaguera C, Fernández-Luque A, Sanz-Martínez MT, Viñas-Giménez L, Perurena-Prieto J, Triginer-Gil L, Alcalá-González L, Bravo C, Simeón Aznar CP.   +16 more
europepmc   +1 more source

Prevalence and association testing of antinuclear antibodies and inflammatory bowel disease in Taiwan. [PDF]

PeerJ
Yang TM, Lu FT, Yen HH, Chen YY.
europepmc   +1 more source

Idiopathic Orbital Inflammation Masquerading as Relapse of Seronegative Juvenile Myasthenia Gravis: A Case Report

Journal of Paediatrics and Child Health, EarlyView.
Wenhao Duan, Yanqing Zhang, Wensha Nie, Hongchao Jiang, Huiping Wang   +4 more
wiley   +1 more source

Outcomes of Immune Check Point Inhibitor Use in US Veterans With Pre‐Existing Idiopathic Inflammatory Myopathies: Case Series and Literature Review

ACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Objective Our objective was to identify and describe the clinical characteristics and outcomes in patients with pre‐existing idiopathic inflammatory myopathies (IIMs) in the Veterans Health Administration (VHA) treated with immune checkpoint inhibitors (ICIs). Methods All veterans receiving ICI infusions were identified.
Denis Krutko, Selene Rubino, Gary A. Kunkel, Jessica A. Walsh, Jorge Rojas, Brian C. Sauer, Shardool Patel, Grant W. Cannon, Tawnie J. Braaten   +8 more
wiley   +1 more source

The association between serum antinuclear antibodies and premature ovarian insufficiency: a meta-analysis. [PDF]

J Ovarian Res
Pi T, Hu Z, Luo L, Liu Z.
europepmc   +1 more source

Is COVID-19 severity unrelated to antinuclear antibodies? [PDF]

Transpl Immunol, 2023
Vahabi M, Mirsharif ES, Ghazanfari T.
europepmc   +1 more source